相关实验视频
Updated: Sep 14, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.5K
与TBK1相关的运动神经元疾病与同时出现的真空神经肌病:一个类似于多系统蛋白病的病例
Yasmine Sluyts1, Kristof Van Schil2, Tine Deconinck2
1Department of Neurology, Neuromuscular Reference Centre, Antwerp University Hospital, Antwerp, Belgium.
Neuromuscular disorders : NMD
|July 24, 2025
概括
这项研究详细介绍了一名患有肌缩性侧面硬化症 (ALS) -肌肉病重叠和TBK1基因变异的患者. 它扩大了对TBK1相关疾病的理解,以及它们与VCP相关的多系统蛋白病变的相似之处.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 肌缩性侧面硬化症 (ALS) 和肌肉病可以同时发生,这是一种与罕见的遗传多系统蛋白质病变 (MSP) 相关的表型.
- 在神经系统疾病中,TBK1基因变异越来越多地被发现.
- 与VCP相关的MSP是多系统蛋白质病变的最常见形式.
研究的目的:
- 报告一个ALS-肌肉病症病例与TBK1致病变体重叠.
- 扩大已知的TBK1相关疾病的临床谱.
- 探索与TBK1相关的和与VCP相关的MSP之间的病理生理相似之处.
主要方法:
- 一位75岁患者的临床评估.
- 电肌图 (EMG) 具有混合的肌病和神经性发现.
- 肌肉磁共振成像 (MRI) 和活检分析,包括P62免疫组织化学.
主要成果:
- 该患者呈现出一种明显的ALS-肌肉病重叠表型.
- 肌肉活检显示了边缘真空孔,特别是P62.2的免疫反应.
- 在TBK1基因中发现了一种致病变体.
结论:
- 这种情况扩大了与TBK1突变相关的临床表现.
- 与TBK1相关的疾病与其他MSP共享病理生理特征,例如与VCP相关的疾病.
- 这些发现突显了MSP的遗传异质性.
相关概念视频
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Microtubule Associated Motor Proteins
8.5K
Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular...
8.5K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710

